Virgin Herbert 4
4 · Vir Biotechnology, Inc. · Filed Aug 10, 2022
Insider Transaction Report
Form 4
Virgin Herbert
EVP, Research & CSO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-08-09−7,916→ 125,416 totalExercise: $10.39Exp: 2029-07-12→ Common Stock (7,916 underlying) - Exercise/Conversion
Common Stock
2022-08-09$1.53/sh+70,177$107,371→ 254,584 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-08-09−70,177→ 140,328 totalExercise: $1.53Exp: 2028-01-26→ Common Stock (70,177 underlying) - Exercise/Conversion
Common Stock
2022-08-09$10.39/sh+7,916$82,287→ 262,500 total
Footnotes (2)
- [F1]The option is fully vested and exercisable.
- [F2]1/4 of the shares subject to the stock option vested and become exercisable on July 12, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter.